Genetic engineering may hold key to Lyme disease vaccine

04/6/2010 | USA Today

Researchers found that deactivating one gene in the tick-borne bacteria that cause Lyme disease helped prevent mice from contracting the disease. The hope is that the research by Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention in Fort Collins, Colo., holds the key to a human vaccine.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC